This topic contains a solution. Click here to go to the answer

Author Question: Which of the following groups advocates for improved and effective psychiatric services and consumer ... (Read 62 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
Which of the following groups advocates for improved and effective psychiatric services and consumer empowerment?
 
  a. National Alliance for Mentally Ill (NAMI) Consumer Council
  b. National Mental Health Consumer's Association (NMHCA)
  c. National Association of Psychiatric Survivors (NAPS)
  d. Consumer/Survivor Mental Health Research and Policy Work Group

Question 2

The number one national health problem, causing more deaths, illnesses, and disabilities than any other health condition, is which of the following?
 
  a. Smoking
  b. Drinking
  c. Substance abuse
  d. Caffeine addiction



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Yixagurpuldink

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

ANS: A

Answer to Question 2

ANS: C




melina_rosy

  • Member
  • Posts: 531
Reply 2 on: Jul 8, 2018
Wow, this really help


rleezy04

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library